Emerging pharmacotherapy of tinnitus

12Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

Abstract

One in ten adults has clinically significant subjective tinnitus, and for one in hundred, tinnitus severely affects their quality of life. Despite the significant unmet clinical need for a safe and effective drug targeting tinnitus relief, there is currently not a single FDA-approved drug on the market. Even a drug that produces a small but significant effect would have a huge therapeutic impact. In the last few years, there have been significant advances in i) the understanding of the pathophysiology of the different forms of tinnitus, ii) the establishment of valid animal models and iii) the development of clinical trial methodology. A glimpse of hope is appearing in the horizon as an increasing number of pharmaceutical industries now have compounds targeting tinnitus in their pipeline. © 2011 Informa UK, Ltd.

Cite

CITATION STYLE

APA

Langguth, B., & Elgoyhen, A. B. (2011, December). Emerging pharmacotherapy of tinnitus. Expert Opinion on Emerging Drugs. https://doi.org/10.1517/14728214.2011.644273

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free